Company intelligence / Profile preview

Alynx

Tampa, Florida, United States

Ownership: Private
Development stage: Other

Overview

At the time of the merger, MiMedx (now core entity) was developing biomaterial-based products for soft tissue repair and exploring other medical applications. No clinical results were reported for products at that time

Therapeutic areas: RheumatologyOther
Modalities: BiomaterialsMedical device
Industry: Therapeutic Medical Devices

Partnerships

Shriner’s Hospital for ChildrenUniversity of South Florida Research Foundation (NDGA technology licensee)

Beyond the preview

Go deeper on Alynx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alynx.

Explore the full profile